K182988

Substantially Equivalent

Afinion HbA1c Dx on Afinion 2

Applicant: Alere Technologies AS
Product code: PDJ
Advisory panel: Clinical Chemistry
Date received: 2018-10-29
Decision date: 2018-11-29
Decision: Substantially Equivalent
Clearance type: Special
Location: Oslo, NO

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.